The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,4-dimethoxy-N-(4-(3-nitrophenyl)-5-(piperidin-1-ylmethyl)thiazol-2-yl)benzenesulfonamide ID: ALA3526575
Cas Number: 1008119-83-2
PubChem CID: 24812126
Product Number: D132586, Order Now?
Max Phase: Preclinical
Molecular Formula: C23H26N4O6S2
Molecular Weight: 518.62
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(S(=O)(=O)Nc2nc(-c3cccc([N+](=O)[O-])c3)c(CN3CCCCC3)s2)cc1OC
Standard InChI: InChI=1S/C23H26N4O6S2/c1-32-19-10-9-18(14-20(19)33-2)35(30,31)25-23-24-22(16-7-6-8-17(13-16)27(28)29)21(34-23)15-26-11-4-3-5-12-26/h6-10,13-14H,3-5,11-12,15H2,1-2H3,(H,24,25)
Standard InChI Key: AOZLMMDVJOGGEQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
10.9911 -3.4489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2865 -3.0304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5739 -3.4312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5646 -4.2505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2739 -4.6672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9836 -4.2640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6937 -4.6798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4047 -4.2770 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6871 -5.4970 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8526 -4.6499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1448 -4.2407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5369 -4.7878 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.8710 -5.5349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6843 -5.4467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4641 -6.2436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8744 -6.9503 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.4676 -7.6590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3607 -6.2886 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6962 -7.0336 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6506 -7.6591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2438 -8.3670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6542 -9.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4756 -9.0700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8787 -8.3616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2483 -9.7839 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4311 -9.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8884 -9.7753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4841 -10.4854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1399 -3.4235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4297 -3.0192 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4273 -2.2002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7212 -1.7959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0136 -2.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0165 -3.0234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7271 -3.4322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
7 9 1 0
6 7 1 0
11 12 1 0
10 11 2 0
12 13 1 0
13 14 2 0
14 10 1 0
4 10 1 0
13 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
16 19 2 0
17 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 17 1 0
22 25 1 0
25 26 1 0
23 27 1 0
27 28 1 0
11 29 1 0
29 30 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
M CHG 2 7 1 9 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 518.62Molecular Weight (Monoisotopic): 518.1294AlogP: 4.52#Rotatable Bonds: 9Polar Surface Area: 123.90Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 6.89CX Basic pKa: 7.43CX LogP: 3.51CX LogD: 3.58Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.32Np Likeness Score: -1.83
References 1. Beconi MG, Yates D, Lyons K, Matthews K, Clifton S, Mead T, Prime M, Winkler D, O'Connell C, Walter D, Toledo-Sherman L, Munoz-Sanjuan I, Dominguez C.. (2012) Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048., 40 (12): [PMID:22942319 ] [10.1124/dmd.112.046532 ] 2. Ahamad S, Bhat SA.. (2022) The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease., 65 (24.0): [PMID:36490325 ] [10.1021/acs.jmedchem.2c00799 ]